Summit Therapeutics (NASDAQ:SMMT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Summit Therapeutics (SMMT) operate in?

Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Summit Therapeutics Stock (NASDAQ: SMMT) stock price, news, charts, stock research, profile.

Open	$22.38
Close	$23.52
Volume / Avg.	4.45M / 2.16M
Day Range	$22.38 - $24.21
52 Wk Range	2.10 - 33.89
Market Cap	$17.23B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	69
Short Interest	16.78%
Days to Cover	8.46

Recent News

BioNTech Positioned For Solid Growth Amid Oncology Transition: Analyst

Truist rates BioNTech a Buy, citing its shift to oncology with BNT327 leading the way. Key data updates and growth catalysts are expected by 2025.

Vandana Singh

This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside

Jefferies upgrades Instil Bio to "Buy" with a $52 target, anticipating significant growth for PD-(L)1xVEGF class and SYN2510's potential in cancer treatments.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$22.38
Close	$23.52
Volume / Avg.	4.45M / 2.16M
Day Range	$22.38 - $24.21
52 Wk Range	2.10 - 33.89
Market Cap	$17.23B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	69
Short Interest	16.78%
Days to Cover	8.46

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Summit Therapeutics (SMMT) stock?

You can purchase shares of Summit Therapeutics (NASDAQ:SMMT) through any online brokerage.

View our list of the best stock brokerages

Who are Summit Therapeutics (SMMT) competitors?

Other companies in Summit Therapeutics’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), BeiGene (NASDAQ:ONC), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).

What is the forecast, or price target, for Summit Therapeutics (SMMT) stock?

Summit Therapeutics has a consensus price target of $33.57.

What is the current price for Summit Therapeutics (SMMT)?

The stock price for Summit Therapeutics (NASDAQ: SMMT) is $23.37 last updated January 22, 2025 at 7:54 PM EST.

Does Summit Therapeutics (SMMT) pay a dividend?

There are no upcoming dividends for Summit Therapeutics.

When is Summit Therapeutics (NASDAQ:SMMT) reporting earnings?

Summit Therapeutics’s Q4 earnings are confirmed for Tuesday, February 18, 2025.

Is Summit Therapeutics (SMMT) going to split?

There is no upcoming split for Summit Therapeutics.

What sector and industry does Summit Therapeutics (SMMT) operate in?

Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Summit Therapeutics

Summit Therapeutics (SMMT) Forecast